Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by BlackRock
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16M | 10M | 1.64 |
| 2025-06-30 | $13M | 10M | 1.30 |
| 2025-03-31 | $15M | 13M | 1.15 |
| 2024-12-31 | $37M | 35M | 1.06 |
| 2024-09-30 | $67M | 57M | 1.17 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1